Nexium (esomeprazole) is the first proton pump inhibitor approved for "on-demand" use
July 2007
Nexium (esomeprazole) is the first proton pump inhibitor approved for "on-demand" use in Canada.
Patients on long-term proton pump inhibitors (PPIs) take their prescribed dose less than 50% of the time. They prefer taking them PRN...it costs less and is effective in well-controlled GERD patients.
These are patients who have already received 2 to 4 weeks of a DAILY proton pump inhibitor for heartburn and/or acid reflux...and who don't have erosive esophagitis.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive